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Summary
Facing multidrug resistant (MDR) bacterial pathogens is
one of the most important challenges for our society. The
spread of highly virulent and resistant pathogens can be
described using molecular typing technologies; in particu-
lar, whole genome sequencing (WGS) data can be used
for molecular typing purposes with high resolution. WGS
data analysis can explain the spatiotemporal patterns of
pathogen transmission. However, the transmission be-
tween compartments (human, animal, food, environment)
is very complex. Interoperable and curated metadata are
a key requirement for fully understanding this complexity.
In addition, high quality sequence data are a key element
between centres using WGS data for diagnostic and epi-
demiological applications. We aim to describe steps to im-
prove WGS data analysis and to implement a molecular
surveillance platform allowing integration of high resolu-
tion WGS typing data and epidemiological data.
Keywords: next generation sequencing, whole genome
sequencing, molecular epidemiology, typing, quality as-
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Improving whole genome sequencing quality
on the way to an interoperable surveillance
platform
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Molecular surveillance with spatiotemporal
resolution integrating epidemiological metada-
ta.
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Species_name NCBI taxonomy name
Taxonomy_ID NCBI taxonomy ID
Sample
Isolation_source Human; animal; environmental; food
Isolation_source_detailed Site of isolation e.g., SNOMED CT for
human
Isolation_country Country where the sample was isolated
Isolation_date Date of isolation
Laboratory_ID Unique ID of the laboratory processing
the sample
Patient (if isolation_source == "Human")
Host_age Age of the patient
Host_sex Gender of the patient
Home_address_zip ZIP code of the patient’s home
Home_address_country Country of the patient’s home
Clinic Name of hospital/clinic where patient is
treated
Clinic_ward Ward where patient is staying
Clinic_room Room number where patient is staying
Study_ethical_consent Describes if patient signed a study ethi-
cal consent
Sequencing
Sequencing_lab_ID Unique ID of the sequencing facility/
laboratory
DNA_extraction_kit Kit used for DNA extraction
Library_preparation_kit Kit used for library preparation
Sequencing_platform Technology used for sequencing, e.g.,
Illumina MiSeq
Bioinformatics
Quality_filtering_tool Name (version) of the tool used for
quality filtering reads
Assembly_method Mapping-based assembly; de-novo as-
sembly
Assembly_tool Name (version) of the tool used for
genome assembly
Reference_genome Reference genome used for mapping
(FASTA format)
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Table 2: Selection of surveillance databases, initiatives, and analytical
tools using whole genome sequence information from pathogens
Weblink
Database












@FE3C62< >@56==:?8 @7 DA2E:@E6>A@C2= EC2?D>:DD:@? 6G6?ED
:?4=F5:?8 3@E9 9F>2? 2?5 2?:>2= DEC2:? :?7@C>2E:@? @C
:56?E:7:42E:@? @7 4@>>@? 86?6D 2DD@4:2E65 H:E9 DF446DD7F=
EC2?D>:DD:@? :? 2 9:89=J 2FE@>2E65 H2J ? 255:E:@? 3@E9
A=2E7@C>D 2C6 56A6?56?E @? E96 FA=@25 @7 AC6AC@46DD65 4F
C2E65 2?5 BF2=:EJ 2AAC@G65 +' 2?5 6A:56>:4 52E2 562=
=J 2 7FEFC6 DFCG6:==2?46 A=2E7@C> H@F=5 2FE@>2E:42==J AC6
2DD6DD 52E2 BF2=:EJ 86?@>:4D 2?5 >6E252E2 2?5 E96? 2D<
9F>2? 6IA6CED 7@C G2=:52E:@? :? 2== @C D6=64E65 3@C56C=:?6
42D6D (96D6 2C6 :>A@CE2?E 82AD :? 4FCC6?E E@@=D H9:49
92G6 E@ 36 255C6DD65 E@ 82:? 7FCE96C :?D:89E :?E@ C62=E:>6
EC2?D>:DD:@? 5J?2>:4D (96 C6BF6DE65 <6J 762EFC6D 7@C 2
>@=64F=2C DFCG6:==2?46 52E232D6 2C6 DF>>2C:D65 :? DFAA=6
>6?E2CJ E23=6'	 :? 2AA6?5:I	
(@ 52E6 E96C6 :D ?@ DA64:7:4 A=2E7@C> :? 'H:EK6C=2?5 2?5
FC@A6 E92E 2==@HD E96 :?E68C2E:@? @7 +' 52E2 7C@> G2C:
@FD 5:28?@DE:4 @C C676C6?46 =23@C2E@C:6D H:E9 2 DA64:2= 7@
4FD @? 2?E:3:@E:4 C6D:DE2?46 2?5 G:CF=6?46 :? 4@>3:?2E:@?
H:E9 DA2E:@E6>A@C2= :?7@C>2E:@? 2?5 G:DF2=:D2E:@?D @?
D:56C:?8 E96 :>A24E @7 !& @? @FC D@4:6EJ 2?5 E96 C2A:5=J
6G@=G:?8 5J?2>:4D @7 !& A2E9@86?D E96C6 :D 2 4=62C 2?5
FC86?E?6657@CDF492A=2E7@C>
Steps to the future of dynamic visualisation us-
ing genomic and phylogenetic data.
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Figure 1: NextStrain tool to analyse transmission of pathogens. (A) Phylogenetic tree of the Ebola virus outbreak in West Africa. Colours
represent different geographic regions, and x-axis reflects a time scale during the outbreak. (B) Transmission dynamics modelled in real-time
with new viral strains based on WGS data.
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Figure 2: Envisioned workflow for the surveillance platform.
After isolating a strain, collecting epidemiological data and se-
quencing it, the user uploads raw data and metadata into a central
or local/private database using the submission portal. After sub-
mission, these data are quality controlled and then (semi-)auto-
matically processed, to perform e.g. genome assembly, and MLST,
SNP and resistance calling. The resulting data are used for phylo-
genetics and predictive modelling of e.g. transmission dynamics.
All these data are stored in a structured database with controlled
access, and visualised in a user-friendly interface. For open-data,
the structured database may also be used/queried by other appli-
cations or pushed to external databases and knowledge bases. In
addition to the submission portal, an administration portal will be
developed, notably to manage users and rights, as well as a curat-
ing portal to edit controlled vocabularies and define curated refer-
ence strains and variants (e.g., for resistance).
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AA6?5:I	 Minimum functional features for a future sur-
veillance tool
Table S1: Minimum functional features for a future surveillance tool
Submission portal




Data entry using an online form
Data entry via uploading a structured text file
Use of controlled vocabularies, and ontologies where they exist
Possibility to enter missing, nonmandatory, metadata at a later stage
Quality control, processing, annotation and modelling of data
Quality control raw reads and assemblies to flag poor quality data
Typing (spa, cgMLST, SNPs)
Modelling of transmission dynamics
Annotation of resistance mutations and genes
Annotation of virulence factors
Visualisation portal




Branches lengths represent either time or divergence
Confidence intervals on branch lengths
Zoom in/out of the tree
Map of cases
Display cases and transmission links
Zoom in/out of the map
Resistance, virulence
Colour-code according to pre-defined resistant genotypes
Display presence/absence of resistance genes
Display presence/absence of virulence factors
Filtering
Filter-out displayed strains based on a combination of criteria
Search function
Interpretations
Annotate related strains (clusters)
Administration portal
Data curation
Maintain curated list of reference genomes
Integrate validated genotype-phenotype resistance associations
Define and update controlled vocabularies
Access
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